The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema
Condition(s):Refractory Diabetic Macular EdemaLast Updated:February 5, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Refractory Diabetic Macular EdemaLast Updated:February 5, 2019Unknown status
Condition(s):Retinitis Pigmentosa Associated With CNGB1 MutationsLast Updated:March 1, 2024Recruiting
Condition(s):Ocular Injury; Optic Nerve Diseases; Photoreceptor Degeneration; Blindness,AcquiredLast Updated:January 11, 2022Unknown status
Condition(s):Retinitis PigmentosaLast Updated:June 9, 2011Completed
Condition(s):Macular Degeneration, Dry; Primary Open-angle GlaucomaLast Updated:March 15, 2023Recruiting
Condition(s):Retinal Degeneration; Genetic Disease; Single-Gene Defects; Macular DystrophyLast Updated:July 19, 2017Unknown status
Condition(s):Age-Related Macular DegenerationLast Updated:March 15, 2024Recruiting
Condition(s):Myopic Macular DegenerationLast Updated:July 18, 2016Withdrawn
Condition(s):Macular Degeneration; Age-Related Macular DegenerationLast Updated:July 6, 2016Completed
Condition(s):Parkinson Disease; Age Related Macular DegenerationLast Updated:February 1, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.